Study Summary:
We are currently conducting a dose response study of investigational drug. Placebo controlled plus Lyrica in subject with Diabetic Neuropathic Pain.
Qualified Participants Must:
• Be 18 years of age or older
•
Have stable glucose control with HbA1c between 8 – 11
•
Have distal symmetric chronic sensorimotor polyneuropathy also known as DPN at least for six months and no more than five years
Qualified Participants May Receive:
Ample stipend at the end of the study for time and travel, gas. Free office visits, EKG, lab work and exams related to study.